Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion evidence source_evidence_literature NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion SIO_000772 23504048 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion wasDerivedFrom befree-20150227 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion wasGeneratedBy ECO_0000203 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.